Dr. Guillermo De Angulo
Scientific Advisory Consultants
Professor Michael Matthay
Dr. Eric Bihler
Dr. William T Ko
Biomarck is pleased to announce its inclusion on COVID-19 Drug Treatment Trackers: Milken Institute COVID-19 Treatment and Vaccine Tracker | Artis Ventures
Biomarck is a biopharmaceutical company with a patented technology platform. We utilize anti-MARCKS peptides to develop and license products targeted at difficult to treat diseases.